A randomised, crossover study on an electronic vapour product, a nicotine inhalator and a conventional cigarette. Part A: Pharmacokinetics

Regulatory Toxicology and Pharmacology

Volumn 74, Issue , 2016, Pages 187-192

  Walele, Tanvir ^a   Sharma, Girish ^c   Savioz, Rebecca ^d   Martin, Claire ^d   Williams, Josie ^b  

^a Fontem Ventures   (Netherlands)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c SIMBEC RESEARCH LTD   (United Kingdom)

^d Clinopsis SA   (Switzerland)

Author keywords

Cigarette; Clinical study; Electronic cigarette; Electronic vapour product; Nicotine; Nicotine inhalator; Pharmacokinetics

Indexed keywords

NICOTINE; NICOTINIC AGENT;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BODY MASS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG HALF LIFE; ELECTRONIC CIGARETTE; FLAVOR; HUMAN; HUMAN EXPERIMENT; INHALER; MALE; MAXIMUM PLASMA CONCENTRATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SMOKING; VAPOR; WITHDRAWAL SYNDROME; BLOOD; COMPARATIVE STUDY; HALF LIFE TIME; INHALATIONAL DRUG ADMINISTRATION; METABOLIC CLEARANCE RATE; MIDDLE AGED; NEBULIZER; PREVENTION AND CONTROL; PROCEDURES; SMOKING CESSATION; TOBACCO USE DISORDER; VOLATILIZATION; WALES; YOUNG ADULT;

ADMINISTRATION, INHALATION; ADULT; AGED; AREA UNDER CURVE; CROSS-OVER STUDIES; ELECTRONIC CIGARETTES; HALF-LIFE; HUMANS; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; NEBULIZERS AND VAPORIZERS; NICOTINE; NICOTINIC AGONISTS; SMOKING; SMOKING CESSATION; TOBACCO USE DISORDER; VOLATILIZATION; WALES; YOUNG ADULT;

EID: 84953367029     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2015.12.003     Document Type: Article

References (34)

1. Adkison S.E., et al. Electronic nicotine delivery systems: international tobacco control four-country survey. Am. J. Prev. Med. 2013, 44:207-215.
2. Beard E., et al. Association of amount and duration of NRT use in smokers with cigarette consumption and motivation to stop smoking: a national survey of smokers in England. Addict. Behav. 2015, 40:33-38.
3. Benowitz N.L., et al. Mentholated cigarette smoking inhibits nicotine metabolism. J. Pharmacol. Exp. Ther. 2004, 310:1208-1215.
4. Berg C.J., et al. Cigarette users' interest in using or switching to electronic nicotine delivery systems or smokeless tobacco for harm reduction, cessation, or Novelty: a cross-sectional survey of U.S. Adults. Nicotine Tob. Res. 2014, 17:245-255.
5. Bullen C., et al. Effect of an electronic nicotine delivery device (e cigarette) on desire to smoke and withdrawal, user preferences and nicotine delivery: randomised cross-over trial. Tob. Control 2010, 19:98-103.
6. Dawkins L., Corcoran O. Acute electronic cigarette use: nicotine delivery and subjective effects in regular users. Psychopharmacol. Berl. 2013, 231(2):401-407.
7. Dockrell M., et al. E-Cigarettes: prevalence and attitudes in Great Britain. Nicotine Tob. Res. 2013, 15:1737-1744.
8. EMA Committee for Medicinal Products for Human Use (CHMP). Guideline on the Investigation of Bioequivalence 2010, European Medicines Agency, Last accessed 23/10/2015. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2010/01/WC500070039.pdf.
9. Etter J.F. Levels of saliva cotinine in electronic cigarette users. Addiction 2014, 109:825-829.
10. Etter J.F., Bullen C. Electronic cigarette: users profile, utilization, satisfaction and perceived efficacy. Addiction 2011, 106:2017-2028.
11. EU Directive 2014/40/EU of the European Parliament and of the Council on the approximation of the laws, regulations and administrative provisions of the Member States concerning the manufacture, presentation and sale of tobacco and related products and repealing Directive 2001/37/EC. Official J. Eur. Union 2014, L 127:1-38.
12. Farsalinos K.E., et al. Impact of flavour variability on electronic cigarette use experience: an internet survey. Int. J. Environ. Res. Public Health 2013, 10:7272-7282.
13. Farsalinos K.E., et al. Evaluation of electronic cigarette use (vaping) topography and estimation of liquid consumption: implications for research protocol standards definition and for public health authorities' regulation. Int. J. Environ. Res. Public Health 2013, 10:2500-2514.
14. Farsalinos K.E., et al. Evaluation of electronic cigarette liquids and aerosol for the presence of selected inhalation toxins. Nicotine Tob. Res. 2014, 17:168-174.
15. Farsalinos K.E., et al. Nicotine absorption from electronic cigarette use: comparison between first and new-generation devices. Sci. Rep. 2014, 4:4133.
16. Goniewicz M.L., et al. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob. Control 2013, 23(2):133-139.
17. Hajek P., et al. Nicotine intake from electronic cigarettes on initial use and after 4 Weeks of regular use. Nicotine Tob. Res. 2014, 17(2):175-179.
18. HC Health Canada. Guidance Document. Conduct and Analysis of Comparative Bioavailability Studies 2012, Last accessed 23/10/2015. http://www.hc-sc.gc.ca/dhp-mps/alt_formats/pdf/prodpharma/applic-demande/guide-ld/bio/gd_cbs_ebc_ld-eng.pdf.
19. Heatherton T.F., et al. The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom tolerance questionnaire. Br. J. Addict. 1991, 86:1119-1127.
20. Hutzler C., et al. Chemical hazards present in liquids and vapors of electronic cigarettes. Arch. Toxicol. 2014, 88:1295-1308.
21. IOM The Institute of Medicine, Clearing the Smoke. Assessing the Science Base for Tobacco Harm Reduction 2011, National Academy Press, ISBN: 0-309-07282-4.
22. King B.A., et al. Awareness and ever use of electronic cigarettes among U.S. Adults, 2010-2011. Nicotine Tob. Res. 2013, 15(9):1623-1627. 1623-7.
23. Kosmider L., et al. Carbonyl compounds in electronic cigarette vapors: effects of nicotine solvent and battery output voltage. Nicotine Tob. Res. 2014, 16:1319-1326.
24. MHRA Press Release: UK Moves towards Safe and Effective Electronic Cigarettes and Other Nicotine-containing Products 2013, 2013, Last accessed 23/10/2015. http://webarchive.nationalarchives.gov.uk/20141205150130/http://www.mhra.gov.uk/NewsCentre/Pressreleases/CON286855.
25. MHRA Licensing Procedure for Electronic Cigarettes and Other Nicotine Containing Products (NCPs) as Medicines 2015, Last accessed 23/10/2015. http://www.mhra.gov.uk/home/groups/comms-ic/documents/websiteresources/con297583.pdf.
26. Orr M.S. Electronic cigarettes in the USA: a summary of available toxicology data and suggestions for the future. Tob. Control 2014, 23(Suppl. 2). ii18-22.
27. Roche Cobas B 221 Blood Gas Analyser System. Instructions for Use. Roche Reference Number 03261395001 2009, Roche Diagnostics, Charles Avenue, Burgess Hill, West Sussex, UK.
28. Spindle T.R., et al. Preliminary results of an examination of electronic cigarette user puff topography: the effect of a mouthpiece-based topography measurement device on plasma nicotine and subjective effects. Nicotine Tob. Res. 2015, 17:142-149.
29. Talih S., et al. Effects of user puff topography, device voltage, and liquid nicotine concentration on electronic cigarette nicotine yield: measurements and model predictions. Nicotine Tob. Res. 2015, 17:150-157.
30. Vansickel A.R., Eissenberg T. Electronic cigarettes: effective nicotine delivery after acute administration. Nicotine Tob. Res. 2013, 15:267-270.
31. Vansickel A.R., et al. A clinical laboratory model for evaluating the acute effects of electronic "cigarettes": nicotine delivery profile and cardiovascular and subjective effects. Cancer Epidemiol. Biomark. Prev. 2010, 19:1945-1953.
32. Walele T., et al. A Randomised, Crossover Study on an Electronic Vapour Product, a Nicotine Inhalator and a Conventional Cigarette. Part B: Safety and Subjective Effects. Regul. Toxicol. Pharmacol. 2016, 74:193-199.
33. Wang J., et al. The effect of menthol containing cigarettes on adult smokers' exposure to nicotine and carbon monoxide. Regul. Toxicol. Pharmacol. 2010, 57:24-30.
34. Werley M.S., et al. Possible effects on smokers of cigarette mentholation: a review of the evidence relating to key research questions. Regul. Toxicol. Pharmacol. 2007, 47:189-203.